Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  Biotech  >  Current Article

Amgen’s patent-related legal disputes resolved

By   /   Monday, January 7th, 2019  /   Comments Off on Amgen’s patent-related legal disputes resolved

    Print       Email
Two patent-related disputes involving Amgen products were resolved in the first days of 2019, temporarily halting sales of a competitor for one of its top products but clearing the way for another rival drug to hit the markets. The Supreme Court announced its decision Jan. 7 not to hear an appeal by the Thousand Oaks-based…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Mindbody to buy billion-dollar fitness company, fueling talk of new IPO

Read More →